If you have researched more than one stem cell clinic, you may have noticed that some describe their cells as “fresh” while others use “cryopreserved” or “frozen” cells. Neither term by itself tells you whether a treatment is high quality. What matters is understanding the difference and knowing what to ask about the specific product you would receive.

What “Fresh” Usually Means

Freshly processed cells are typically isolated and prepared close to the time they are administered, without being frozen in between. This approach is most common with same-day, autologous procedures, where cells are harvested from a patient’s own tissue (such as bone marrow or fat) and processed in the clinic’s lab before being returned to the same patient within hours. The cells never go through a freeze-thaw cycle.

What “Frozen” or “Cryopreserved” Usually Means

Cryopreserved cells are processed, tested, and then frozen for storage, often at very low temperatures using a cryoprotectant solution designed to protect the cells during freezing. They are thawed shortly before use. This approach is common with donor-derived (allogeneic) cells, such as those sourced from umbilical cord or placental tissue, because freezing allows a lab to complete quality testing on a batch before it is ever shipped to a clinic, and it allows cells to be stored and transported over distance and time.

Rocky Point Stem Cell Therapy’s own FAQ on where stem cells come from notes that we use allogeneic mesenchymal stem cells obtained through a cryopreservation process, with viability confirmed at the time of transplantation. That is one example of how a clinic should be able to describe its own process specifically, rather than leaving the fresh-versus-frozen question unanswered.

Neither Approach Is Automatically Better

Fresh and cryopreserved cells each come with different tradeoffs, and the right choice often depends on the type of treatment being offered rather than one method being universally superior.

  • Fresh, same-day cells avoid any freeze-thaw stress entirely, but because they are processed quickly, there is typically less time to complete full laboratory testing before the cells are used.
  • Cryopreserved cells can be tested for sterility, identity, and viability before release, giving the clinic documented results ahead of treatment. The tradeoff is that the freezing and thawing process itself can affect cell viability, which is why reputable labs report a viability percentage measured specifically at the time of thaw or administration.

Questions to Ask Your Clinic

Rather than assuming one method is automatically better, ask the clinic to explain their specific process:

  • Are the cells used in my treatment fresh or cryopreserved?
  • If cryopreserved, what is the cell viability at the time of thaw or administration, and how is that measured?
  • Is testing for sterility, identity, and contamination performed before freezing, after thawing, or both?
  • How long is the cell product stored before use, and how is it transported?
  • How much time passes between thawing (or processing, for fresh cells) and actual administration?

A clinic that can answer these questions specifically, rather than simply asserting that its cells are “high quality,” is giving you something you can actually evaluate. For more on what “certified” claims mean in this context, see our article on what “certified stem cells” means, and for a broader look at why a high advertised cell count on its own does not guarantee a good outcome, see why cell count alone does not show treatment quality.

If you have questions about how Rocky Point Stem Cell Therapy sources, tests, and handles the cells used in your treatment, contact our team — we are happy to walk through our process in detail.

Table of Contents